Related Experiment Video
Updated: Jul 27, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Community-Acquired Pneumonia: An Overview.
1Division of Infectious Diseases, Department of Internal Medicine, Wayne State University School of Medicine/Detroit Medical Center; and Harper Hospital, 4 Yellow Center, 3990 John R., Detroit, MI 48201, USA.
Community-acquired pneumonia (CAP) is a major cause of illness and death, especially in older adults. Current guidelines emphasize pathogen-specific treatment, but more data is needed to assess the impact of these approaches on care quality and cost.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Community-acquired pneumonia (CAP) represents a significant burden on healthcare systems, leading to numerous hospitalizations, outpatient visits, and substantial costs.
- The elderly population is disproportionately affected, accounting for over 90% of pneumonia-related fatalities.
- While Streptococcus pneumoniae is traditionally considered the primary pathogen, atypical pathogens are increasingly recognized, particularly in ambulatory patients.
Purpose of the Study:
- To review current understanding of CAP etiology, risk factors, and mortality.
- To examine the impact of antimicrobial resistance on empiric CAP therapy.
- To evaluate the role and effectiveness of recent practice guidelines in managing CAP.
Main Methods:
- Literature review of recent studies on CAP epidemiology, treatment, and outcomes.
- Analysis of data concerning mortality risk and process of care in CAP patients.
- Examination of the implications of increasing Streptococcus pneumoniae resistance on therapeutic strategies.
Main Results:
- Emerging evidence suggests atypical pathogens may be more prevalent than previously assumed in CAP.
- Increasing antimicrobial resistance in Streptococcus pneumoniae necessitates adjustments in empiric treatment protocols.
- Recent guidelines advocate for pathogen-specific therapy, guided by diagnostic tests like sputum Gram stain and culture.
Conclusions:
- Despite the development of practice guidelines for CAP management, robust data on their impact on healthcare quality and cost is still lacking.
- Further research is required to ascertain the real-world effectiveness of guideline-driven interventions for CAP.
- The evolving landscape of CAP pathogens and antimicrobial resistance underscores the need for adaptive management strategies.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia
Pneumonia I: Introduction

